Bentham Science has entered into a collaboration with Spanish Society of Pharmacology (SEF) for our High Impact journals including Current Neuropharmacology (JCR IF: 7.36), Current Medicinal Chemistry (JCR IF: 4.53), Current Topics in Medicinal Chemistry (JCR IF: 3.295), and Current Pharmaceutical Design (JCR IF: 3.116). This collaboration facilitates members of the society to publish their research in Bentham journals with significant concessions.

The SEF was founded in 1972 to bring together all Spanish pharmacologists, in order to facilitate organizing scientific meetings (an annual meeting at the national level) with the aim of promoting scientific and social exchange among Spanish pharmacologists as well as joint meetings with other Pharmacology Societies within the framework of the International Pharmacology Association and the European Pharmacology Association (IUPHAR and EPHAR). The Society represents researchers in national and international organizations, helps networking at scientific and technical meetings, awards scholarships and prizes to stimulate pharmacological research in Spain. In addition, it manages the operation of different working committees reviewing specific issues in pharmacology and allied research.

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies and Information on our journals’ indexation, by various indexing agencies, can be viewed at https://benthamscience.com/index.php.

Learn more in our press release: https://bit.ly/2W75YGo